Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 75/100

Failure Rate

20.0%

1 terminated/withdrawn out of 5 trials

Success Rate

80.0%

-6.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
5(100.0%)
5Total
N/A(5)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT05494229Not ApplicableTerminated

Autologous Blood for Full-thickness Macular Hole

Role: lead

NCT05269563Not ApplicableCompleted

Double Flap Technique for Macular Hole

Role: lead

NCT05494242Not ApplicableCompleted

Single Superior ILM/ERM Flap for the FTMH.

Role: lead

NCT05278949Not ApplicableCompleted

Re-fixating Dislocated Scleral Fixing Intra-ocular Lens

Role: lead

NCT05278936Not ApplicableCompleted

New Technique in Congenital/Pediatric Cataract Surgery

Role: lead

All 5 trials loaded